Français
Home
About Us
Science
Our People
Media Center
Contact Us
Resources
Careers
Global Site
You are now leaving Mitsubishi Tanabe Pharma Canada and visiting a third-party website.
Cancel
Continue
If you are interested in exploring careers at MTP-CA, please email
contact@mt-pharma-canada.com
.
Close
Mitsubishi Tanabe Pharma Canada Announces that Company’s Oral Treatment Formulation for Amyotrophic Lateral Sclerosis (ALS) Has Been Added to the Provincial Drug Plans in Prince Edward Island, Newfoundland and Labrador
